Jonathan Jay Mazelsky, President & CEO at IDEXX LABORATORIES INC /DE (IDXX), sold 15,900 shares at $275.72 ($4.4M) on 2020-02-05, disclosed to the SEC on 2020-02-07.
Open-market sale of $4.4M IDXX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $275.72 | 1,145 | $316K | 7.1% |
| 2 | $275.72 | 1,145 | $316K | 7.1% |
| 3 | $276.71 | 1,337 | $370K | 8.4% |
| 4 | $276.71 | 1,337 | $370K | 8.4% |
| 5 | $277.88 | 3,354 | $932K | 21.1% |
| 6 | $277.88 | 3,354 |
| $932K |
| 21.1% |
| 7 | $279.01 | 1,676 | $468K | 10.6% |
| 8 | $279.01 | 1,676 | $468K | 10.6% |
| 9 | $280.13 | 100 | $28K | 0.6% |
| 10 | $281.97 | 388 | $109K | 2.5% |
| 11 | $281.97 | 388 | $109K | 2.5% |
| Total | $277.82 avg | 15,900 | $4.4M | 100% |
| Filing → |
| IDXX | SELL | 2024-02-09 | $13.7M | — | Filing → |
| IDXX | SELL | 2023-12-06 | $7.3M | — | Filing → |
| IDXX | SELL | 2023-09-05 | $13.7M | — | Filing → |